Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-IMG-76987

Xenbase Image ID: 76987

Supplementary Fig. 1. Inhibiting Vegf signalling with KRN633, a vegfr specific inhibitor does not recapitulate the SU5402 phenotype. Treating embryos with either 10 μM, or 25 μM KRN633 leads to a loss of angiogenesis when embryos are assayed for either etv2 (G–L) or aplnr (M–R) as demonstrated by a loss of vascular budding in the ventral trunk, and a loss of intersomitic vessels (white arrow heads). However, no concentration tested was able to block expression of tnni3 (A–F), or cause significant truncations of the tail.

Image published in: Deimling SJ and Drysdale TA (2011)

Copyright © 2011. Image reproduced with permission of the Publisher, Elsevier B. V.

GeneSynonymsSpeciesStage(s)Tissue
tnni3.Lc-troponin, cardiac tropin T, cardiac troponin I, cTnI, ctnIc, cTNT, TIc, TnIc, tnnic, troponin-ic, XcTnI, XTnIcX. laevisThroughout NF stage 28 to NF stage 29 and 30 
etv2.Ler71, ets1, ets2-like, Etsrp, etsrp71X. laevisThroughout NF stage 28 to NF stage 29 and 30periotic region
anterior lymph sac
cardinal vein
intersomitic vessel
vascular plexus
aortic arch
aplnr.Lagtrl1, angio1, apj, apjr, aplnr-a, aplnr-b, hg11, msr, X-msr, Xangio1, XmsrX. laevisThroughout NF stage 28 to NF stage 29 and 30periotic region
head region
tail tip
aortic arch
cardinal vein
intersomitic vessel
vascular plexus

Image source: Published

Larger Image
Printer Friendly View

Return to previous page